Liver: Difference between revisions

From Radiology Protocols
Jump to navigation Jump to search
No edit summary
No edit summary
 
(10 intermediate revisions by 3 users not shown)
Line 1: Line 1:
Priority Description<br />
1. P1 High probability of potentially life threatening condition <br />
2. P2 High probability of condition potentially causing significant long term harm <br />
3. P3 Possibility of potentially life threatening condition <br />
4. P4 Possibility of condition potentially causing significant long term harm <br />
5. P5 Unlikely to be life threatening or cause significant long term harm  <br />
<br />
{| class="wikitable"
|-
!Protocol code
!When to use
|-
| ?Ca 2Wk
|| ? Cancer 2ww – use as normal – scan to be scheduled within 2 weeks
|-
| Urgent
|| Urgent – use as normal – scan to be scheduled within 4 weeks
|-
| COVID – Semi Urgent
|| Examination needs performing during next few months
|-
| Routine
|| Do not use during Covid pandemic
|-
| COVID P5 Cancel
|| Examination is P5 exam and will be cancelled and re refer back to clinician
|-
| Cancel
|| Examination to be cancelled due to non-justification of examination only ( not due to COVID)
|-
| On hold
|| Use as normal
|}
All routine are reclassified as above.
{| class="wikitable"
{| class="wikitable"
|-
|-
! Indication
! Indication
! COVID Cancel
! COVID Urgent
! Brief description
! Brief description
! Slice thickness and reconstruction kernel
! Slice thickness and reconstruction kernel
Line 10: Line 50:
|
|
Cholangiocarcinoma?
Cholangiocarcinoma?
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
Triple phase liver (Art/PV/5 min delayed)
Triple phase liver (Art/PV/5 min delayed)
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
Bolus tracked as above.
Bolus tracked as above.
Line 23: Line 65:
|
|
Staging cholangiocarcinoma
Staging cholangiocarcinoma
||
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
|colspan="4"|
Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis
Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis


Line 30: Line 74:
|
|
Follow up cholangiocarcinoma
Follow up cholangiocarcinoma
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
5 min delayed liver and PV Chest, abdomen and pelvis
5 min delayed liver and PV Chest, abdomen and pelvis
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
As above
As above
Line 43: Line 89:
|
|
Characterise liver lesion/HCC
Characterise liver lesion/HCC
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
CT triple phase liver
CT triple phase liver
Line 49: Line 97:
(No pelvis required unless clinically indicated)
(No pelvis required unless clinically indicated)
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
ROI placed over aorta, monitoring begins after 10 seconds and bolus tracking triggers scan at 100 HU with a delay of 12 seconds. After arterial scan 30 s delay till PV scan.
ROI placed over aorta, monitoring begins after 10 seconds and bolus tracking triggers scan at 100 HU with a delay of 12 seconds. After arterial scan 30 s delay till PV scan.
Line 59: Line 107:
|
|
Hepatocellular carcinoma staging
Hepatocellular carcinoma staging
||
|| <!--Put an X after the angled bracket if COVID Cancel -->
Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis
|| <!--Put an X after the angled bracket if COVID Urgent -->X
|colspan="4"|Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis




|-
|-
|
|rowspan="2"|Liver metastases
Liver metastases
|rowspan="2"| <!--Put an X after the angled bracket if COVID Cancel -->
||
|rowspan="2"| <!--Put an X after the angled bracket if COVID Urgent -->X
CT liver
|rowspan="2"|CT liver
Depends on primary site.
Depends on primary site.
If colorectal only need PV phase.
If colorectal only need PV phase.
Breast/renal/neuroendocrine/melanoma/sarcoma/lung usually include chest
Breast/renal/neuroendocrine/melanoma/sarcoma/lung usually include chest
||
|rowspan="2"|
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.
If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.
Line 81: Line 130:
|-
|-
|
|
||
||
Breast, melanoma, lung:
Breast, melanoma, lung:
Arterial chest and liver
Arterial chest and liver
Line 93: Line 140:
|
|
Haemangioma
Haemangioma
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->
||
||
CT triple phase liver and delayed
CT triple phase liver and delayed
Art, PV and 5 minute liver
Art, PV and 5 minute liver
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
MRI preferable (see new protocol for incidental liver lesion pick up).
MRI preferable (see new protocol for incidental liver lesion pick up).
Line 108: Line 157:
|
|
Post TACE
Post TACE
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
CT triple phase liver (arterial/portal venous/5 min delayed)
CT triple phase liver (arterial/portal venous/5 min delayed)
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
Bolus tracked as above.
Bolus tracked as above.
Line 121: Line 172:
|
|
Post RFA
Post RFA
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
CT triple phase liver (pre/arterial/portal venous/5 min delayed)
See either Liver metastases protocol or HCC protocol, some people want pre contrast
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
Bolus tracked as above.
Bolus tracked as above.
||
||
CT quad phase liver
See either Liver metastases protocol or HCC protocol




Line 134: Line 187:
|
|
Post embolisation f/u of HCC
Post embolisation f/u of HCC
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
||
Aterial, portal venous and delayed phases
Aterial, portal venous and delayed phases
||
||
1.5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
||
Bolus tracked as above.
Bolus tracked as above.
Line 145: Line 200:


|-
|-
|
|rowspan="2"|Post embolization f/u of liver metastatic deposit
Post embolization f/u of liver metastatic deposit
|rowspan="2"| <!--Put an X after the angled bracket if COVID Cancel -->
||
|rowspan="2"| <!--Put an X after the angled bracket if COVID Urgent -->X
CT arterial or arterial/PV liver
|rowspan="2"|CT arterial or arterial/PV liver
||
|rowspan="2"|1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
1.5 mm B30f, 1.2 mm increment.
||
||
If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.
If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.
Line 158: Line 212:


|-
|-
|
|Breast, melanoma, lung:
||
||
Breast, melanoma, lung:
40 seconds chest and liver
40 seconds chest and liver
65 seconds abdomen and pelvis
65 seconds abdomen and pelvis
Line 168: Line 219:




|-
|
Splenic lesions
|| <!--Put an X after the angled bracket if COVID Cancel -->
|| <!--Put an X after the angled bracket if COVID Urgent -->X
||
Triple phase abdomen
||
1.5 mm B30f, 5 mm B30f, 1.2 mm increment.
||
As above
||
CT triple phase spleen
|}
|}

Latest revision as of 13:45, 12 January 2021

Priority Description
1. P1 High probability of potentially life threatening condition
2. P2 High probability of condition potentially causing significant long term harm
3. P3 Possibility of potentially life threatening condition
4. P4 Possibility of condition potentially causing significant long term harm
5. P5 Unlikely to be life threatening or cause significant long term harm

Protocol code When to use
?Ca 2Wk ? Cancer 2ww – use as normal – scan to be scheduled within 2 weeks
Urgent Urgent – use as normal – scan to be scheduled within 4 weeks
COVID – Semi Urgent Examination needs performing during next few months
Routine Do not use during Covid pandemic
COVID P5 Cancel Examination is P5 exam and will be cancelled and re refer back to clinician
Cancel Examination to be cancelled due to non-justification of examination only ( not due to COVID)
On hold Use as normal

All routine are reclassified as above.

Indication COVID Cancel COVID Urgent Brief description Slice thickness and reconstruction kernel Further details of contrast timing/explanation of what the radiographers do Abbreviation

Cholangiocarcinoma?

X

Triple phase liver (Art/PV/5 min delayed)

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

Bolus tracked as above.

Triple phase liver (Art/PV/5 min)


Staging cholangiocarcinoma

X

Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis


Follow up cholangiocarcinoma

X

5 min delayed liver and PV Chest, abdomen and pelvis

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

As above

CAP with 5 min delayed liver


Characterise liver lesion/HCC

X

CT triple phase liver Usually do not require pre-contrast unless possible focal fat, etc. Non contrast, arterial, PV and 5 minute delayed liver. (No pelvis required unless clinically indicated)

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

ROI placed over aorta, monitoring begins after 10 seconds and bolus tracking triggers scan at 100 HU with a delay of 12 seconds. After arterial scan 30 s delay till PV scan.

CT Quad/triple Phase Liver


Hepatocellular carcinoma staging

X Appropriate scans according to recent characterisation scan and whatever else is needed e.g. chest and pelvis


Liver metastases X CT liver

Depends on primary site. If colorectal only need PV phase. Breast/renal/neuroendocrine/melanoma/sarcoma/lung usually include chest

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.

CT PV liver


Breast, melanoma, lung: Arterial chest and liver 65 seconds abdomen and pelvis

CT Art + PV liver


Haemangioma

CT triple phase liver and delayed Art, PV and 5 minute liver

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

MRI preferable (see new protocol for incidental liver lesion pick up). Bolus tracked as above.

CT triple phase liver


Post TACE

X

CT triple phase liver (arterial/portal venous/5 min delayed)

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

Bolus tracked as above.

CT triple phase liver


Post RFA

X

See either Liver metastases protocol or HCC protocol, some people want pre contrast

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

Bolus tracked as above.

See either Liver metastases protocol or HCC protocol


Post embolisation f/u of HCC

X

Aterial, portal venous and delayed phases

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

Bolus tracked as above.

CT triple phase liver


Post embolization f/u of liver metastatic deposit X CT arterial or arterial/PV liver 1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

If colorectal, lung, squamous cell, adeno ca. (hypovascular) 65 seconds abdomen and pelvis.

CT PV liver


Breast, melanoma, lung:

40 seconds chest and liver 65 seconds abdomen and pelvis

CT art + PV liver


Splenic lesions

X

Triple phase abdomen

1.5 mm B30f, 5 mm B30f, 1.2 mm increment.

As above

CT triple phase spleen